Engines and Pioneers: China's Auto Industry Heads Towards a New Decade
Engines and Pioneers: China's Auto Industry Heads Towards a New Decade
ContributorsBob Wang
EditorLuke Sheehan
Pages25
CopyrightEqualOcean Intelligence
Download For Free
Introduction
The COVID-19 pandemic has accelerated the adoption of technology in the auto industry. Governments, such as those of China, France, Italy, are using electric vehicle subsidies to stimulate the economy and build a more sustainable world. Legacy car makers, like General Motors and Daimler, are investing lavishly in related projects. In this report, we comprehensively analyze China's automotive industry and indicate the main investment opportunities appearing within the sector.
Highlights
- NIO, Li Auto and Xpeng are taking sizable losses, but are still highly valued by the markets
- Legacy automakers have been suffering, with their stocks delivering low returns
- Tesla's market dominance has made global incumbents join the game
- We are rather optimistic about China's New Energy Vehicle (NEV) market, which is hugely driven by government support, improving infrastructure and the rise of local Chinese brands
- China's dominance in the EV segment is continuing: to date, ~1.2 million EVs, or 57% of global sales, have occured in the country
Contents
- 1 Introduction
- 2 Highlights
- 3 2020 - The transformation year
- 4 EV at the tipping point
- 5 Case study: Li Auto
- 6 Case study: BYD
- 7 Autonomous car commercialization contest
- 8 Chinese tech giants' mega-billion game
- 9 Autonomous and electric systems
- 10 Case study: Huayu
In this report
27
charts showcasing the status quo of the Chinese auto market
45
companies were analyzed in this report, with two case studies -- veteran automaker BYD and Chinese EV upstart Li Auto
Related Companies
Selected reports
Automotive
Financing and Investment Activities in China's Mobility Industry From 2012 to 2022
Oct 07, 2022 09:33 AM
CONTACT US
Scan QR code to contact us for professional consulting services
Read next
Insight
In-depth
Insight
In-depth
Healthcare
Immunotherapy in China: A Rising Star in the Field of Cancer Treatment
Nov 24, 2022 06:29 PM
Insight
In-depth
Healthcare
Challenges and Opportunities Possessed by Digital Therapeutics Industry
Nov 23, 2022 03:23 PM